Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 21, 2005; 11(27): 4210-4214
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4210
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4210
Figure 1 A: Change in mean heartburn score after treatment of itopride.
The heartburn score of patients with GERD was improved in both groups of itopride significantly. bP < 0.0001, 1P = 0.0006 vs pretreatment by paired t-test; B: Change in mean total symptom score after treatment of itopride. The mean total symptom score of patients with GERD was improved in both groups of itopride significantly. dP < 0.0001 vs pretreatment by paired t-test.
Figure 2 Change in mean number of acid refluxes after itopride treatment.
Mean number of acid refluxes was significantly improved in 300-mg group. 1P = 0.057 vs pretreatment by Wilcoxon’s signed rank test.
Figure 3 Change in mean level of prolactin after itopride treatment.
The level of prolactin was not changed after treatment of itopride in GERD.
- Citation: Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, Nah YH, Choi MG, Choi SC. Effect of itopride, a new prokinetic, in patients with mild GERD: A pilot study. World J Gastroenterol 2005; 11(27): 4210-4214
- URL: https://www.wjgnet.com/1007-9327/full/v11/i27/4210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i27.4210